Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.45M Sell
12,663
-10
-0.1% -$998 2.75% 5
2023
Q3
$1.15M Buy
12,673
+2,875
+29% +$297K 2.26% 7
2023
Q2
$1.1M Buy
9,798
+2,444
+33% +$258K 1.83% 9
2023
Q1
$770K Sell
7,354
-3,204
-30% -$335K 1.31% 17
2022
Q4
$1.17M Sell
10,558
-484
-4% -$50.7K 1.91% 8
2022
Q3
$965K Buy
11,042
+1,161
+12% +$106K 1.56% 11
2022
Q2
$772K Buy
9,881
+1,039
+12% +$85.8K 1.1% 24
2022
Q1
$754K Buy
8,842
+930
+12% +$89.1K 0.91% 39
2021
Q4
$949K Buy
+7,912
New +$982K 0.92% 36

Other funds holding XYL

Sonen Capital's XYL Position: Q4 2023 in Review

Sonen Capital reduced its Xylem (XYL) stake by 0.08% in Q4 2023, selling an estimated $998 and leaving 12,663 shares worth $1.45M. The position accounts for 2.75% of the portfolio, ranked #5.

Sonen Capital first reported a position in XYL in Q4 2021 and has held it in 9 quarters since. 922 funds tracked by Wall St. Rank hold XYL as of Q4 2023.

  • Sonen Capital held 12,663 shares of Xylem worth $1.45M as of Q4 2023.
  • Sonen Capital sold 10 Xylem shares in Q4 2023, an estimated $998.
  • Xylem made up 2.75% of Sonen Capital's portfolio in Q4 2023, its #5 holding.
  • Sonen Capital first reported a position in Xylem in Q4 2021 and has held it in 9 quarters since.
  • 922 funds tracked by Wall St. Rank held Xylem as of Q4 2023.

Based on Sonen Capital's 13F filing for Q4 2023, filed 2 Feb 2024.